• / Free eNewsletters & Magazine
  • / My Account
Home>Alnylam Reports Positive Interim Phase 1 Results for Fitusiran in Hemophilia A and B Patients with Inhibitors

Alnylam Reports Positive Interim Phase 1 Results for Fitusiran in Hemophilia A and B Patients with Inhibitors

3party Content

Sat, 3 Dec 2016

Alnylam Reports Positive Interim Phase 1 Results for Fitusiran in Hemophilia A and B Patients with Inhibitors
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.